What GLP-1 Drugs Actually Cost You Each Month

Two people start the same GLP-1 medication on the same day, at the same dose, from the same pharmacy chain. One pays $50 a month. The other pays $1,350.

Neither of them did anything wrong. They just entered through different doors.

GLP-1 pricing is one of the most confusing areas in consumer healthcare, and the confusion is expensive. Survey work from KFF found that about half of people taking these drugs say they are difficult to afford, and a large share of that difficulty comes from not knowing which payment path applies to them.

Here is what each door actually costs, with the yearly totals worked out.

Key Takeaways

• About one in eight US adults currently takes a GLP-1, and 18% have taken one at some point, according to KFF polling of 1,350 adults.
• Retail list prices run roughly $1,271 to $1,640 per month, but very few people pay list.
• Manufacturer direct programs sell the same drugs for $199 to $449 a month depending on dose.
• With commercial insurance that covers weight treatment, copays typically fall to $25 to $150 a month, though prior authorization is usually required.
• The annual gap between the worst path and the best is over $15,000 for the identical medication.

How Many People This Actually Affects

Adoption moved faster than most health trends of the last decade. KFF polling puts 12% of US adults, roughly one in eight, currently taking a GLP-1, with 18% having taken one at some point.

Usage concentrates where the clinical case is strongest. Around four in ten adults with diabetes report having taken one, as do one in four adults with heart disease.

Measured at the household level the number climbs higher still. Analysis by PwC using Numerator consumer data found that roughly 21% of US households included a current GLP-1 user by May, up from 9% in January of the previous year.

Those two figures, 12% of adults and 21% of households, are not in conflict. A household counts if anyone in it uses the drug, so the household number will always run higher. More than doubling in sixteen months is the part worth noticing.

The Four Payment Paths

Almost everyone pays through one of four channels, and the difference between them is enormous.

1. Retail list price

Walking into a pharmacy with no insurance and no program, the sticker is roughly $1,350 to $1,640 a month for Wegovy and about $1,271 a month for Zepbound. This is the number that generates headlines. It is also the number the fewest people actually pay.

2. Manufacturer direct programs

Both manufacturers now sell straight to self-paying patients, and this is the path most people without coverage are missing.

Through NovoCare Pharmacy, Wegovy runs an introductory $199 a month for the first two months at starting doses, then $349 a month, with the higher dose pen at $399.

Through LillyDirect, Zepbound is priced by dose: $299 at the lowest, $399 at the next step, and $449 for the higher doses.

Same drug, same manufacturer, roughly a third of the retail price.

3. Commercial insurance

If your employer plan covers weight treatment, copays typically land between $25 and $150 a month. The catch is access rather than price. Plans generally require prior authorization and documented clinical criteria, commonly a BMI of 30 or above, or 27 with a related condition.

Many plans exclude weight loss indications entirely while covering the same molecule for diabetes. That single line in your plan document is worth more than any coupon.

4. Medicare

A Medicare GLP-1 Bridge program running from July through the end of the following year gives eligible Part D beneficiaries certain GLP-1 drugs at a $50 monthly copay. Eligible products include Wegovy in injection and tablet form and the Zepbound KwikPen.

The Yearly Math Nobody Runs

Monthly prices are easy to underestimate because these are not short courses. Most clinical guidance treats GLP-1 therapy as ongoing. So the number that matters is annual.

Take a full year at a mid-range dose:

• Retail list at $1,350/month: $16,200 a year
• Manufacturer direct at $399/month: $4,788 a year
• Commercial insurance at $80/month: $960 a year
• Medicare Bridge at $50/month: $600 a year

The spread between the top and bottom of that list is $15,600 a year for the same medication. That is not a discount. That is the difference between a car payment and a phone bill.

Now the step most people skip. Take the realistic self-pay path at $4,788 a year and divide by twelve: $399 a month, every month, indefinitely. Against a median household budget that is roughly equivalent to adding a second car payment with no end date.

The question to answer before starting is not whether you can afford the first month. It is whether you can afford month eighteen, because stopping tends to reverse the benefit. Budgeting for an open-ended commitment is a different exercise from budgeting for a purchase, and the same structural approach we covered in why budgets fail for reasons other than discipline applies here: automate it as a fixed line item rather than treating it as a monthly decision.

Five Questions Worth Asking Before You Start

Each of these can move your cost by hundreds of dollars a month.

• Does my plan cover this for weight, or only for diabetes? These are separate coverage decisions and plans frequently allow one and exclude the other.
• What does prior authorization require? Ask for the specific clinical criteria in writing, because the documentation is usually the bottleneck rather than the decision.
• Is the manufacturer direct price lower than my copay? With a high deductible plan, the answer is sometimes yes, and nobody at the pharmacy counter will tell you.
• What happens to the price when my dose increases? Manufacturer direct pricing is tiered by dose, so your cost rises as you titrate up.
• What is the plan if coverage ends? Employer formularies change annually. Knowing the self-pay fallback before you need it prevents an abrupt stop.

For the clinical side of how these drugs work and what the oral versions change, our explainer on the oral GLP-1 pill covers the mechanism. If you are weighing this alongside other health spending, our review of which longevity supplements have evidence behind them is a useful comparison on cost per benefit.

KFF publishes its polling methodology and full results through its health tracking poll on GLP-1 drugs.

Frequently Asked Questions

How much do GLP-1 drugs cost per month?

It depends entirely on how you pay. Retail list prices run about $1,271 to $1,640 a month. Manufacturer direct programs sell the same drugs for $199 to $449 depending on dose. Commercial insurance copays typically fall between $25 and $150, and an eligible Medicare beneficiary may pay $50.

Why is there such a big price difference for the same drug?

Because four separate pricing systems operate in parallel: retail list, manufacturer direct-to-consumer programs, negotiated insurance formularies, and Medicare. Each was built for a different purpose, and nothing automatically routes you to the cheapest one. Over a year the gap between the highest and lowest path exceeds $15,000.

Does insurance cover GLP-1 medications for weight loss?

Some plans do and many do not. Coverage for weight treatment is a separate decision from coverage for diabetes, and plans commonly allow the second while excluding the first. Where it is covered, prior authorization is usually required along with documented criteria such as a BMI of 30, or 27 with a related condition.

How many people are taking GLP-1 drugs?

KFF polling of 1,350 adults found about one in eight US adults currently take a GLP-1 and 18% have taken one at some point. Separate analysis by PwC using Numerator data put roughly 21% of US households as including a current user by May, up from 9% sixteen months earlier.

What happens to the cost if I need a higher dose?

Manufacturer direct pricing is tiered by dose, so the cost rises as you titrate upward. Zepbound through LillyDirect moves from $299 at the lowest dose to $449 at higher ones. Budget against the dose you expect to settle at rather than the one you start on.

The Bottom Line

The sticker price is real, but it is close to a worst case, and treating it as the cost of these drugs stops people from asking the questions that would cut their bill by two thirds.

Find out which of the four doors applies to you before you start, and price the full year rather than the first month. The difference between the best path and the worst is over $15,000 annually for an identical prescription, and closing that gap is mostly a matter of asking.

Disclaimer: This article is for general information only and is not medical advice. Prices, coverage rules, and program eligibility change frequently and vary by plan and region. Talk to a qualified clinician about whether these medications are appropriate for you, and confirm current pricing directly with your insurer or the manufacturer before making decisions.